VIO400. THERAPEUTIC MEDICATION ADDENDUM
- VIO400.1 Does not apply if prohibited by governmental regulations.
- VIO400.2 Exhibitors, owners, trainers and veterinarians are cautioned against the use of medicinal preparations, tonics, pastes and products of any kind, the ingredients and quantitative analysis of which are not specifically known, as many of them may contain a forbidden substance.
- VIO400.3 A Therapeutic Medication Hotline is available by calling 1-800-633-2472.
VIO401. Forbidden drugs or substances include:
- VIO401.1 Any drug or substance considered a Class I or Class II substance as defined in the most recent edition of American Racing Commissioners International Uniform Classification Guidelines for Foreign Substances.
- VIO401.2 Any stimulant, depressant, tranquilizer or sedative which could affect the performance of a horse (stimulants and depressants are defined as substances that stimulate or depress the cardiovascular, respiratory or central nervous system).
- VIO401.3 Any substance, regardless of how harmless or innocuous it might be, that might interfere with the detection or quantitation of any substance defined in VIO401.1 or VIO401.2.
- VIO401.4 Any anabolic steroid in halter classes, VIO402 – VIO403 do not apply.
- VIO401.5 Any nonsteriodal anti-inflammatory drug (NSAID) other than those listed in VIO405.1 – VIO405.8 below.
- VIO401.6 Any metabolite and/or analog of any of the above described forbidden drugs or substances.
VIO402. Conditionally Permitted Therapeutic Medication: Any drug, medication or substance that could affect the performance of a horse that is used for the legitimate treatment of illness or injury and is not specified as a forbidden substance as defined in VIO401.1 or VIO401.5 above shall be considered a conditionally permitted therapeutic medication. However, conditionally permitted therapeutic medications are forbidden and use thereof subjects the person to disciplinary action, unless all conditions of their administration are met.
VIO403. Each of the following requirements is a condition to authorize administration of conditionally permitted therapeutic medications, which shall be verified in a written medication report, available from AQHA or show management, completed in its entirety, and filed with show management before exhibition of the horse per VIO403.3 –
- VIO403.1 Administration by a veterinarian who is licensed to practice veterinary medicine in the state, province or country where the event is being held (“Licensed Veterinarian”) or from a written prescription (written instructions) by a Licensed Veterinarian which documents administration of medication is necessary for the legitimate treatment of illness or injury. The administration of a conditionally permitted therapeutic medication for the purpose of transport, grooming, training, etc. is not therapeutic under this authorization rule.
- VIO403.2 The horse must be withdrawn and kept out of competition for not less than 24 hours after the medication is administered.
- VIO403.3 Identification of the medication: the name, amount, strength/concentration and mode of administration.
- VIO403.4 Date and time of administration.
- VIO403.5 Identification of the horse: name, age, sex, color and entry number.
- VIO403.6 Diagnosis of illness/injury, reason for administration, and name of administering and/or prescribing AAEP veterinarian.
- VIO403.7 Signature of veterinarian or person administering the medication. If by prescription (written instructions), a copy must be attached to the medication report.
- VIO403.8 The medication report must be filed with show management within one hour after administration of the medication or one hour after show management is available, if administration occurs at a time other than during competition hours.
- VIO403.9 The medication report must be signed by show management and time of receipt recorded on the report.
- VIO403.10 While the medication report must be filed only if the administered medication will be present in amounts detectable in blood and/or urine samples at the time of competition/sampling, exhibitors are hereby cautioned it is their responsibility to determine whether or not such medication has had time to clear the horse’s system. If there is any doubt, a medication report should be filed.
- VIO403.11 Regardless of whether the medication report requirements described above are met, laboratory detection of concentration levels of an otherwise conditionally permitted therapeutic drug that are inconsistent with the administration of a therapeutic dosage of such drug (including, but not limited to, inconsistencies regarding reported dosage and time constraints) shall constitute presumption of a violation of this rule, and the Responsible Party has the burden of persuasion to establish that the drug was administered in a therapeutic dosage and not less than 24 hours prior to competition.
- VIO403.12 Regardless of whether all of the conditionally permitted therapeutic medication requirements listed in VIO403 are met, it shall be considered a rule violation if the same plasma or urine sample contains more than one (1) of the permitted NSAIDs listed in VIO405.1 - VIO405.8
VIO404. Restrictions concerning the use of conditionally permitted therapeutic medications that may be administered within 24 hours of showing:
- VIO404.1 Subject to the specified restrictions, only those thirteen (13) drugs or medications listed in VIO405.1 – VIO405.13 below may be administered within 24 hours of showing. The provisions in VIO405.1 – VIO405.13 below contain rules concerning maximum allowable plasma concentration levels followed by “Guidelines”. The
Guidelines are applicable to most horses. Nevertheless, reliance upon the guidelines does not guarantee compliance with the rules, since the response of individual horses may vary. Exhibitors, owners, and trainers should consult the drug manufacturer and knowledgeable veterinarians for up-to-date information and more specific advice concerning the therapeutic use of a drug or medication for a particular horse.
The Guidelines, if heeded, will minimize the chances of positive drug tests. However, all Responsible Parties are cautioned that the guidelines are only general guidelines, and it is their responsibility to see to it that conditions prevail for full compliance with all AQHA rules. Reliance upon the Guidelines will not serve as a defense to a charge of violation of the rule in the event of a positive drug test.
Should the testing laboratory report the presence of one of the drugs or medications listed in VIO405.1 – VIO405.13 below in an amount greater than what would be consistent with the Guidelines or at a level higher than a specified maximum permitted plasma concentration, the matter will be reviewed and disciplinary action may be taken.
- VO404.2 Regardless of whether all of the conditionally permitted therapeutic medication requirements for a specific NSAID listed in VIO405.1 – VIO405.8 below are met, it shall be considered a rule violation if the same plasma or urine sample contains more than one (1) of the NSAIDs listed in VIO405.1 - VIO405.8 below.